|
gptkbp:instanceOf
|
gptkb:biotechnology
gptkb:public_company
|
|
gptkbp:CEO
|
gptkb:Emma_Walmsley
|
|
gptkbp:chairman
|
gptkb:Jonathan_Symonds
|
|
gptkbp:country
|
gptkb:United_Kingdom
|
|
gptkbp:divested
|
Haleon (consumer healthcare)
|
|
gptkbp:focus
|
gptkb:HIV
immunology
infectious diseases
oncology
pharmaceuticals
vaccines
specialty medicines
|
|
gptkbp:founded
|
2000
|
|
gptkbp:headquarters_location
|
gptkb:London,_England,_United_Kingdom
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
GSK plc
|
|
gptkbp:industry
|
gptkb:biotechnology
pharmaceuticals
|
|
gptkbp:ISIN
|
GB00BN7SWP63
|
|
gptkbp:marketCap
|
~£60 billion (2023)
|
|
gptkbp:member
|
gptkb:FTSE_100_Index
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
|
|
gptkbp:notablePerson
|
gptkb:Emma_Walmsley
gptkb:Jonathan_Symonds
gptkb:Jean-Pierre_Garnier
gptkb:Sir_Andrew_Witty
|
|
gptkbp:numberOfEmployees
|
~69,000 (2023)
|
|
gptkbp:predecessor
|
gptkb:Glaxo_Wellcome
gptkb:SmithKline_Beecham
|
|
gptkbp:product
|
gptkb:Advair
gptkb:Augmentin
gptkb:Avodart
gptkb:Flovent
gptkb:Lamictal
gptkb:Seretide
gptkb:Shingrix
gptkb:Ventolin
HIV medicines
Hepatitis vaccines
Meningitis vaccines
Oncology medicines
|
|
gptkbp:revenue
|
£29.3 billion (2023)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:London_Stock_Exchange
gptkb:New_York_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:GSK
|
|
gptkbp:subsidiary
|
gptkb:Stiefel_Laboratories
gptkb:ViiV_Healthcare
|
|
gptkbp:website
|
https://www.gsk.com/
|
|
gptkbp:bfsParent
|
gptkb:GSK_Egypt
gptkb:Dame_Emma_Walmsley
|
|
gptkbp:bfsLayer
|
7
|